In vitro modeling of COPD inflammation and limitation of p38 inhibitor – SB203580

References

• EngstromGSegelstormNEkberg-AronssonMNilssonPMLindgardeFLofdahlCGPlasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort studyThorax2009643211211518988660
   PubMed Web of Science ®Google Scholar
• O’DonnellRAPeeblesCWardJARelationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPDThorax2004591083784215454648
   PubMed Web of Science ®Google Scholar
• SaettaMDi StefanoATuratoGCD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 18228269517597
   PubMed Web of Science ®Google Scholar
• PesciABalbiBMajoriMInflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary diseaseEur Respir J19981223803869727789
   PubMed Web of Science ®Google Scholar
• PelemanRARytilaPHKipsJCJoosGFPauwelsRAThe cellular composition of induced sputum in chronic obstructive pulmonary diseaseEur Respir J199913483984310362050
   PubMed Web of Science ®Google Scholar
• FinkelsteinRFraserRSGhezzoHCosioMGAlveolar inflammation and its relation to emphysema in smokersAm J Respir Crit Care Med19951525 Pt 1166616727582312
   PubMed Web of Science ®Google Scholar
• KaradagFKarulABCildagOYilmazMOzcanHBiomarkers of systemic inflammation in stable and exacerbation phases of COPDLung2008186640340918807087
   PubMed Web of Science ®Google Scholar
• Di FranciaMBarbierDMegeJLOrehekJTumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19941505 Pt 1145314557952575
   PubMed Web of Science ®Google Scholar
• MinakataYNakanishiMHiranoTMatsunagaKYamagataTIchinoseMMicrovascular hyperpermeability in COPD airwaysThorax2005601088216055610
   PubMed Web of Science ®Google Scholar
• YangIAClarkeMSSimEHFongKMInhaled corticosteroids for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20127CD00299122786484
   PubMed Web of Science ®Google Scholar
• SaklatvalaJThe p38 MAP kinase pathway as a therapeutic target in inflammatory diseaseCurr Opin Pharmacol20044437237715251131
   PubMed Web of Science ®Google Scholar
• LomasDALipsonDAMillerBEAn oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary diseaseJ Clin Pharmacol201252341642422090363
   PubMed Web of Science ®Google Scholar
• WatzHBarnacleHHartleyBFChanREfficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trialLancet Respir Med201421637224461903
   PubMed Web of Science ®Google Scholar
• RendaTBaraldoSPelaiaGIncreased activation of p38 MAPK in COPDEur Respir J2008311626917959643
   PubMed Web of Science ®Google Scholar
• GaffeyKReynoldsSPlumbJKaurMSinghDIncreased phosphorylated p38 mitogen-activated protein kinase in COPD lungsEur Respir J2013421284123060629
   PubMed Web of Science ®Google Scholar
• ArmstrongJHarbronCLeaSSynergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary diseaseJ Pharmacol Exp Ther2011338373274021610141
   PubMed Web of Science ®Google Scholar
• NaikDJoshiAPaulTVThomasNChronic obstructive pulmonary disease and the metabolic syndrome: consequences of a dual threatIndian J Endocrinol Metab201418560861625285275
   PubMedGoogle Scholar
• TsaiJJLiaoECHsuJYLeeWJLaiYKThe differences of eosinophil- and neutrophil-related inflammation in elderly allergic and non-allergic chronic obstructive pulmonary diseaseJ Asthma20104791040104420858153
   PubMed Web of Science ®Google Scholar
• FujimotoKKuboKYamamotoHYamaguchiSMatsuzawaYEosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysemaChest1999115369770210084478
   PubMed Web of Science ®Google Scholar
• LindenMRasmussenJBPiitulainenEAirway inflammation in smokers with nonobstructive and obstructive chronic bronchitisAm Rev Respir Dis19931485122612328239158
   PubMed Web of Science ®Google Scholar
• PanznerPLafitteJJTsicopoulosAHamidQTulicMKMarked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients with chronic bronchitis with obstructionChest200312451909191514605067
   PubMed Web of Science ®Google Scholar
• ChungKFCytokines in chronic obstructive pulmonary diseaseEur Respir J Suppl20013450s59s12392035
   PubMed Web of Science ®Google Scholar
• RichEAPanuskaJRWallisRSWolfCBLeonardMLEllnerJJDyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophagesAm Rev Respir Dis19891394101010162784642
   PubMed Web of Science ®Google Scholar
• LevineSJLariveePLogunCAngusCWOgnibeneFPShelhamerJHTumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cellsAm J Respir Cell Mol Biol19951221962047865217
   PubMed Web of Science ®Google Scholar
• TosiMFStarkJMSmithCWHamedaniAGruenertDCInfeldMDInduction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesionAm J Respir Cell Mol Biol1992722142211353976
   PubMed Web of Science ®Google Scholar
• WuTIkezonoTAngusCWShelhamerJHTumor necrosis factor-alpha induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cellsBiochim Biophys Acta1996131021751848611631
   PubMed Web of Science ®Google Scholar
• MoermansCHeinenVNguyenMLocal and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary diseaseCytokine201156229830421880505
   PubMed Web of Science ®Google Scholar
• ZhangLChengZLiuWWuKExpression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patientsCOPD201310445946523537276
   PubMedGoogle Scholar
• ZhuXGadgilASGivelberRPeripheral T cell functions correlate with the severity of chronic obstructive pulmonary diseaseJ Immunol200918253270327719234225
   PubMed Web of Science ®Google Scholar
• LehmannCWilkeningALeiberDLymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune systemAnat Rec2001264322923611596005
   PubMedGoogle Scholar
• MengAHZhangXPShiYNThe role of p-38MAPK and STAT3 in LPS-stimulated mouse alveolar macrophageExp Ther Med2014861772177625371731
   PubMed Web of Science ®Google Scholar
• MengAHWangBZhangXPQiNLiuDCWuJKAdditive suppression of LPS-induced IL-10 and TNF-g XP,pre-treatment of dexamethasone and SB203580 in a murine alveolar macrophage cell Line (MH-S)Inflammation20153831260126625563207
   PubMed Web of Science ®Google Scholar
• MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
   PubMed Web of Science ®Google Scholar
• SandfordAJSilvermanEKChronic obstructive pulmonary disease. 1: susceptibility factors for COPD the genotype-environment interactionThorax200257873674112149538
   PubMed Web of Science ®Google Scholar
• ReynierFde VosAFHoogerwerfJJGene expression profiles in alveolar macrophages induced by lipopolysaccharide in humansMol Med2012181303131122952057
   PubMed Web of Science ®Google Scholar